Grants and Contributions:

Agreement Number:
-
Agreement Value:
$105,000.00
Agreement Date:
May 1, 2012 - Apr 30, 2015
Description:
Glyoxalase-1 and Cell Therapy in Defective Ischemia-induced Neovascularization in Diabetes
Organization:
Canadian Institutes of Health Research
Location:
Ottawa, Ontario, CA K1Y 4W7
Reference Number:
236-2012-2013-Q1-00084
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2012-13 to 2015-16)

Start date may be subject to change. Funding for awards must commence within 12 months of the date of offer.

Recipient's Legal Name:
VULESEVIC, Branka
Research Organization:
Ottawa Heart Institute Research Corporation (Ontario)